VBIV VBI Vaccines Inc

VBI Vaccines Inc is a biopharmaceutical company. It is engaged in developing novel technologies that seek to expand vaccine protection in large underserved markets.

$2.56  -0.08 (-3.03%)
As of 05/11/2021 09:35:07 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  02/12/2013
Outstanding shares:  254,195,435
Average volume:  3,171,934
Market cap:   $706,663,309
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    91822J103
ISIN:        CA91822J1030
Sedol:      BYVFL64
Valuation   (See tab for details)
PE ratio:   -14.52
PB ratio:   3.80
PS ratio:   666.04
Return on equity:   -26.92%
Net income %:   -4,357.21%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy